Hypomorphic CARD11 mutations associated with diverse immunologic phenotypes with or without atopic disease.

Batsukh Dorjbal, Jeffrey R Stinson, Chi A Ma, Michael A Weinreich, Bahar Miraghazadeh, Julia M Hartberger, Stefanie Frey-Jakobs, Stephan Weidinger, Lena Moebus, Andre Franke, Alejandro A Schäffer, Alla Bulashevska, Sebastian Fuchs, Stephan Ehl, Sandhya Limaye, Peter D Arkwright, Tracy A Briggs, Claire Langley, Claire Bethune, Andrew F Whyte, Hana Alachkar, Sergey Nejentsev, Thomas DiMaggio, Celeste G Nelson, Kelly D Stone, Martha Nason, Erica H Brittain, Andrew J Oler, Daniel P Veltri, T Ronan Leahy, Niall Conlon, Maria C Poli, Arturo Borzutzky, Jeffrey I Cohen, Joie Davis, Michele P Lambert, Neil Romberg, Kathleen E Sullivan, Kenneth Paris, Alexandra F Freeman, Laura Lucas, Shanmuganathan Chandrasakan, Sinisa Savic, Sophie Hambleton, Smita Y Patel, Michael B Jordan, Amy Theos, Jeffrey Lebensburger, T Prescott Atkinson, Troy R Torgerson, Ivan K Chinn, Joshua D Milner, Bodo Grimbacher, Matthew C Cook, Andrew L Snow
Year of publication:
Journal title abbreviated:
Journal title long:
Journal of allergy and clinical immunology
Impact factor:
CARD11 encodes a scaffold protein in lymphocytes that links antigen receptor engagement with downstream signaling to NF-κB, JNK, and mTORC1. Germline CARD11 mutations cause several distinct primary immune disorders in humans, including SCID (biallelic null mutations), B cell Expansion with NF-κB and T cell Anergy (BENTA; heterozygous, gain-of-function mutations), and severe atopic disease (loss-of-function, heterozygous, dominant interfering mutations), which has focused attention on CARD11 mutations discovered by whole exome sequencing.To determine the molecular actions of an extended allelic series of CARD11, and to characterize the expanding range of clinical phenotypes associated with heterozygous CARD11 loss-of-function alleles.Cell transfections and primary T cell assays were utilized to evaluate signaling and function of CARD11 variants.Here we report on an expanded cohort of patients harboring novel heterozygous CARD11 mutations that extend beyond atopy to include other immunologic phenotypes not previously associated with CARD11 mutations. In addition to (and sometimes excluding) severe atopy, heterozygous missense and indel mutations in CARD11 presented with immunologic phenotypes similar to those observed in STAT3-LOF, DOCK8 deficiency, common variable immune deficiency (CVID), neutropenia, and immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX)-like syndrome. Pathogenic variants exhibited dominant negative activity, and were largely confined to the CARD or coiled-coil domains of the CARD11 protein.These results illuminate a broader phenotypic spectrum associated with CARD11 mutations in humans, and underscore the need for functional studies to demonstrate that rare gene variants encountered in expected and unexpected phenotypes must nonetheless be validated for pathogenic activity.